Authors:
LUNDBERG F
FALKENBACK D
BEKASSY AN
JENNERBERG M
RIESENFELD J
LJUNGH A
Citation: F. Lundberg et al., DOXORUBICIN REVERSIBLY DECREASES THE ANTITHROMBOGENICITY OF HEPARIN IMMOBILIZED ON CENTRAL VENOUS CATHETERS, Pediatric hematology and oncology, 15(1), 1998, pp. 23-35
Citation: J. Sanchez et al., STUDIES OF ADSORPTION, ACTIVATION, AND INHIBITION OF FACTOR-XII ON IMMOBILIZED HEPARIN, Thrombosis research, 89(1), 1998, pp. 41-50
Citation: J. Sanchez et al., ANTITHROMBIN MEDIATED INHIBITION OF THE PLASMA CONTACT ACTIVATION SYSTEM ON IMMOBILIZED HEPARIN, Thrombosis and haemostasis, 1997, pp. 854-854
Citation: J. Sanchez et al., INHIBITION OF THE PLASMA CONTACT ACTIVATION SYSTEM OF IMMOBILIZED HEPARIN - RELATION TO SURFACE-DENSITY OF FUNCTIONAL ANTITHROMBIN BINDING-SITES, Journal of biomedical materials research, 37(1), 1997, pp. 37-42
Authors:
MOLLNES TE
RIESENFELD J
GARRED P
NORDSTROM E
HOGASEN K
FOSSE E
GOTZE O
HARBOE M
Citation: Te. Mollnes et al., A NEW MODEL FOR EVALUATION OF BIOCOMPATIBILITY - COMBINED DETERMINATION OF NEOEPITOPES IN BLOOD AND ON ARTIFICIAL SURFACES DEMONSTRATES REDUCED COMPLEMENT ACTIVATION BY IMMOBILIZATION OF HEPARIN, Artificial organs, 19(9), 1995, pp. 909-917
Citation: J. Sanchez et al., CONTROL OF CONTACT ACTIVATION ON END-POINT IMMOBILIZED HEPARIN - THE ROLE OF ANTITHROMBIN AND THE SPECIFIC ANTITHROMBIN-BINDING SEQUENCE, Journal of biomedical materials research, 29(5), 1995, pp. 655-661
Citation: G. Elgue et al., ON THE MECHANISM OF COAGULATION INHIBITION ON SURFACES WITH END-POINTIMMOBILIZED HEPARIN, Thrombosis and haemostasis, 70(2), 1993, pp. 289-293